BioPharm International-12-01-2012

December 01, 2012

Job Security in a Changing BioPharma Environment

December 01, 2012

A UC Berkeley survey provides insight into biopharma's risk concerns and strategies.

December 01, 2012

The author examines the use of closures for products intended for injection.

December 01, 2012

Preparation of biological samples for chromatographic analyses.

December 01, 2012

The South Korean market is characterized by its aging population and an affluent population. Growth potential is limited as it has evolved to a developed market and industry players expect it to have established regulations.

December 01, 2012

Keeping tabs on crucial medicines should be part of consumers' and manufacturers' emergency-preparedness plans.

December 01, 2012

White House and Congress likely to struggle over funding for bio/pharmaceutical regulation.

December 01, 2012

Can postapproval FDA filings immunize pharma companies from patent lawsuits?

December 01, 2012

An introduction to a new series on manufacturing within global markets.

December 01, 2012

Recent research examines the sequence of events underlying cellular reprogramming, which may aid in better control of the production of induced pluripotent stem cells.

December 01, 2012

NIBRT's Pauline Rudd on what to expect when performing glycan analysis.

December 01, 2012

Results from the 2012 employment survey.

December 01, 2012

The authors describe the development of an ultra scale-down anion exchange membrane adsorber, and demonstrate scalability to larger-scale devices.

December 01, 2012

This month, Sharon Strause, an industry consultant, provides a look back at "Computer System Validation Part I: Testing and Verification of Applications Software" by Leonard J. Goren.